ESPAÑOL ENGLISH

Ceballos Santos, Daniel Sebastián

Publicaciones

All

Articles

Review

Annotation

Lecture

Others

Type

12 artículo
1 tesis doctoral

By researcher

By affiliation

Title Issue Date
Experience of Tofacitinib use in pregnancy in patients with ulcerative colitis Chaparro, María; Ceballos Santos, Daniel Sebastián ; Vicente, Raquel; Gisbert, Javier P. Issued date: 2024 DOI: 10.1007/s40261-024-01353-3 Source: Clinical Drug Investigation [1173-2563], v. 44, pp. 285-288 (Marzo 2024) SJR: 0,68 - Q2 JCR: 3,2 - Q3 SCIE Artículo
Persistencia, eficacia y seguridad del tratamiento con ustekinumab y vedolizumab para la fístula perianal compleja en la enfermedad de Crohn: el estudio HEAL de GETECCU Casanova, María José; Caballol, Berta; Sánchez García, María José; Mesonero, Francisco; Rubín de Célix, Cristina, et al Issued date: 2024 DOI: 10.1016/j.dld.2024.05.009 Source: Digestive and Liver Disease, [ISSN 1590-8658], (Junio 2024). SJR: 0,873 - Q2 JCR: 4,5 - Q2
Clinical Approach to STRIDE-II in Real-life Settings: Analysis and Practical Recommendations Ricart, Elena; Bastida, Guillermo; Carpio, Daniel; Ceballos Santos, Daniel Sebastián ; Ginard, Daniel, et al Issued date: 2024 DOI: 10.1093/crocol/otae055 Source: Crohn's & Colitis 360 [2631-827X], otae055, (Octubre 2024) SJR: 0,708 - Q2 Artículo
Long‐term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study Chaparro, María; Hermida, Sandra; Acosta, Diana; Fernández Clotet, Agnès; Arroyo, Maite, et al Issued date: 2024 DOI: 10.1111/apt.18230 Source: Alimentary Pharmacology and Therapeutics [ISSN 0269-2813], p. 1-14, (Sep 2024). SJR: 2,794 - Q1 JCR: 7,6 - Q1 SCIE MIAR ICDS: 11,0
Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus González-Lama, Yago; Ricart, Elena; Carpio, Daniel; Bastida, Guillermo; Ceballos Santos, Daniel Sebastián , et al Issued date: 2024 DOI: 10.1136/bmjgast-2023-001246 Source: BMJ Open Gastroenterology [2054-4774], v. 11(1):e001246 (Enero 2024) SJR: 1,083 - Q1 ESCI Artículo
Mirikizumab as induction and maintenance therapy for ulcerative colitis D'Haens, Geert; Dubinsky, Marla; Kobayashi, Taku; Irving, Peter M.; Howaldt, Stefanie, et al Issued date: 2023 DOI: 10.1056/NEJMoa2207940 Source: New England Journal of Medicine [0028-4793], v. 388(26), pp. 2444-2455 (Junio 2023) SJR: 20,544 - Q1 JCR: 158,5 - Q1 SCIE MIAR ICDS: 11,0 Artículo
The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making Bastida Paz, Guillermo; Merino Ochoa, Olga; Aguas Peris, Mariam; Barreiro-De Acosta, Manuel; Zabana, Yamile, et al Issued date: 2023 DOI: 10.1159/000531789 Source: Digestive Diseases [0257-2753], v. 41(6), pp. 879-889 (Diciembre 2023) SJR: 0,744 - Q2 JCR: 2,3 - Q4 SCIE MIAR ICDS: 11,0 Artículo
Activity of Spanish gastroenterology units before and after the COVID-19 pandemic: an assessment using the EFIC_AD tool, developed by the Sociedad Española de Patología Digestiva (SEPD) Poves, Elvira; Carballo, Fernando; Ceballos Santos, Daniel Sebastián ; Alberca de las Parras, Fernando Issued date: 2023 DOI: 10.17235/reed.2023.9860/2023 Source: REV ESP ENFERM DIG. [ISSN 1130-0108], v.115 (11), p. 636-643, (2023). SJR: 0,324 - Q3 JCR: 2,0 - Q4 SCIE MIAR ICDS: 11,0
Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study Marín Jiménez, Ignacio; Acosta, Manuel Barreiro de; Esteve, María; Castro Laria, Luisa; García López, Santiago, et al Issued date: 2022 DOI: 10.1016/j.gastrohep.2021.04.010 Source: Gastroenterologia y Hepatologia, [ISNN 0210-5705]. v. 45, (3), p. 165-176, (2022). SJR: 0,237 - Q3 JCR: 1,9 - Q4 SCIE MIAR ICDS: 11,0
Predictors: How to approach the individualization of treatment Ceballos Santos, Daniel Sebastián Issued date: 2021 DOI: 10.1093/ibd/izaa228 Source: Inflammatory Bowel Diseases, [ISNN 1078-0998], v. 27 (11), p. 1876-1877, (2021). SJR: 1,706 - Q1 JCR: 7,29 - Q1 SCIE MIAR ICDS: 11,0
Diet and microbiome in the beginning of the sequence of gut inflammation Ceballos Santos, Daniel Sebastián ; Hernández Camba, A.; Ramos, L. Issued date: 2021 DOI: 10.12998/wjcc.v9.i36.11122 Source: World Journal of Clinical Cases, [ISNN 2307-8960], v. 9 (36), p. 1122-11147, (2021). SJR: 0,38 - Q3 JCR: 1,534 - Q4 SCIE MIAR ICDS: 8,4
Sleep quality, quality of life, and patient-reported outcomes Ceballos Santos, Daniel Sebastián Issued date: 2020 DOI: 10.1093/ibd/izz277 Source: Inflammatory Bowel Diseases, ÎSNN 1078-0998], v. 26 (8, p. 1260, (2020). SJR: 1,932 - Q1 JCR: 5,325 - Q2 SCIE
Predictive factors of clinical response to treatment with anti-TNF agents in ulcerative colitis: What have we learned from our patients? Ramos, Laura; Hernández Camba, Alejandro; Barreda, Raquel De La; Vela, Milagros; Alonso Abreu, Inmaculada, et al Issued date: 2020 DOI: 10.17235/REED.2020.6688/2019 Source: Revista Espanola de Enfermedades Digestivas, [ISSN 1130-0108], v. 112 (8), p. 636-641, (2020). SJR: 0,331 - Q3 JCR: 2,086 - Q4 SCIE
Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial Taxonera, C; López-Sanromán, A; Vera-Mendoza, I; Domènech, E; Ruiz, VV, et al Issued date: 2019 DOI: 10.1016/j.dld.2019.01.002 Source: Digestive and Liver Disease [1590-8658], v. 51(4), pp. 529-535 (Abril 2019) SJR: 0,941 - Q2 JCR: 3,57 - Q2 SCIE Artículo
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain Chaparro, M.; Barreiro de Acosta, M.; Benítez, JM; Cabriada, JL; Casanova, MJ, et al Issued date: 2019 DOI: 10.1177/1756284819847034 Source: Therapeutic Advances in Gastroenterology, [ISNN 1756-283X], v.12, (January-December 2019). SJR: 1,29 - Q1 JCR: 3,52 - Q2 SCIE
Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab Saro, C; Ceballos Santos, Daniel Sebastián ; Muñoz, F; de-la-Coba, C; Aguilar, MD, et al Issued date: 2017 DOI: 10.17235/reed.2016.4600/2016 Source: Revista Española de Enfermedades Digestivas [1130-0108], v. 109(2), pp. 122-129 (Febrero 2017) SJR: 0,417 - Q3 JCR: 1,632 - Q4 SCIE Artículo
Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial López-Sanromán, A; Vera-Mendoza, I; Domènech, E; Taxonera, C; Ruiz, VV, et al Issued date: 2017 DOI: 10.1093/ecco-jcc/jjx051 Source: Journal of Crohn's and Colitis [1873-9946], v. 11(11), pp. 1293-1301 (Octubre 2017) SJR: 2,728 - Q1 JCR: 6,637 - Q1 SCIE Artículo
Niveles de biológicos: eficacia e inmunogenicidad del tratamiento para enfermedad inflamatoria intestinal Ceballos Santos, Daniel Sebastián Advisor: Fiuza Pérez, Mª Dolores Issued date: 2016 Tesis doctoral
Perforaciones duodenales tras colangiopancreatografía retrógrada endoscópica Armas Ojeda, María Desirée; Ojeda Marrero, Vanesa; Roque Castellano, Cristina ; Cabrera Marrero, José Carlos; Mathías Gutierrez, María del Pino, et al Issued date: 2015 DOI: 10.1016/j.ciresp.2015.01.004 Source: Cirugia Espanola [ISSN 0009-739X], v. 93 (6), p. 403-410 SJR: 0,251 - Q3 JCR: 1,0 - Q3 SCIE Artículo
Resources utilization and costs the yearbBefore and after starting treatment with Adalimumab in Crohn's Disease patients Saro, C; Ceballos Santos, Daniel Sebastián ; Muñoz, F; De la Coba, C; Aguilar, MD, et al Issued date: 2015 DOI: 10.1097/MIB.0000000000000413 Source: Inflammatory Bowel Diseases, [ISNN 1078-0998], v. 21 (7), p. 1631-1640, (July 2015) SJR: 2,348 - Q1 JCR: 4,358 - Q1 SCIE